Sun Pharma Rises After Breast Cancer Drug Launch
Sun Pharmaceutical Industries Ltd. launches Palbociclib, a novel targeted therapy for advanced breast cancer.
Palbociclib helps delaying disease progression when co-administered with hormonal therapies.
